Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PITX1
|
ENSG00000069011.11 | paired like homeodomain 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PITX1 | hg19_v2_chr5_-_134369973_134369988 | -0.04 | 8.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_161035655 | 10.09 |
ENST00000600454.1
|
AL591806.1
|
Uncharacterized protein |
chr5_-_55224569 | 8.37 |
ENST00000595799.1
|
AC008914.1
|
Uncharacterized protein |
chr12_-_66317967 | 8.08 |
ENST00000601398.1
|
AC090673.2
|
Uncharacterized protein |
chr19_-_2256405 | 6.80 |
ENST00000300961.6
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1 |
chr22_-_24096562 | 6.72 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr22_-_24096630 | 6.60 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr11_-_118213455 | 6.49 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr7_+_73623717 | 6.05 |
ENST00000344995.5
ENST00000460943.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chr16_+_30386098 | 5.72 |
ENST00000322861.7
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr11_-_118213331 | 5.63 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr1_+_160765947 | 5.20 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
chr7_+_142031986 | 5.08 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chrX_-_70326455 | 5.02 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
chr16_-_29757272 | 5.01 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
chr7_+_142334156 | 4.98 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
chr11_-_118213360 | 4.94 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr17_-_3599696 | 4.89 |
ENST00000225328.5
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr1_-_179457805 | 4.88 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
chr16_+_30484021 | 4.70 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr2_+_234104079 | 4.60 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr17_-_18950950 | 4.51 |
ENST00000284154.5
|
GRAP
|
GRB2-related adaptor protein |
chr16_+_30483962 | 4.50 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr20_-_46041046 | 4.37 |
ENST00000437920.1
|
RP1-148H17.1
|
RP1-148H17.1 |
chr14_+_22111077 | 4.37 |
ENST00000390423.2
|
TRAV1-2
|
T cell receptor alpha variable 1-2 |
chr22_-_21360736 | 4.33 |
ENST00000547793.2
|
AC002472.1
|
Uncharacterized protein |
chr19_-_54327542 | 4.32 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
chr20_-_42355629 | 4.31 |
ENST00000373003.1
|
GTSF1L
|
gametocyte specific factor 1-like |
chr1_+_180941695 | 4.30 |
ENST00000457152.2
|
AL162431.1
|
Uncharacterized protein |
chr7_+_73624327 | 4.25 |
ENST00000361082.3
ENST00000275635.7 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chr19_+_14693888 | 4.15 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
chr19_-_17932314 | 4.09 |
ENST00000598577.1
ENST00000317306.7 ENST00000379695.5 |
INSL3
|
insulin-like 3 (Leydig cell) |
chr19_+_10751715 | 3.97 |
ENST00000430975.1
|
AC011475.1
|
Uncharacterized protein |
chr16_-_68014732 | 3.97 |
ENST00000268793.4
|
DPEP3
|
dipeptidase 3 |
chr17_+_26638667 | 3.94 |
ENST00000600595.1
|
AC061975.10
|
Uncharacterized protein |
chr17_-_37934466 | 3.85 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr14_+_22089953 | 3.79 |
ENST00000542354.1
|
TRAV1-1
|
T cell receptor alpha variable 1-1 |
chr17_-_3599492 | 3.70 |
ENST00000435558.1
ENST00000345901.3 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr22_+_42095497 | 3.69 |
ENST00000401548.3
ENST00000540833.1 ENST00000400107.1 ENST00000300398.4 |
MEI1
|
meiosis inhibitor 1 |
chr2_+_203104292 | 3.66 |
ENST00000594829.1
|
AC079354.2
|
Uncharacterized protein |
chr1_-_24239844 | 3.61 |
ENST00000374472.4
|
CNR2
|
cannabinoid receptor 2 (macrophage) |
chr16_-_30394143 | 3.61 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
chr16_-_12062333 | 3.59 |
ENST00000597717.1
|
AC007216.2
|
Uncharacterized protein |
chr19_+_544034 | 3.58 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
chr12_-_54691668 | 3.52 |
ENST00000553198.1
|
NFE2
|
nuclear factor, erythroid 2 |
chr19_+_10959043 | 3.48 |
ENST00000397820.4
|
C19orf38
|
chromosome 19 open reading frame 38 |
chr12_-_56756553 | 3.47 |
ENST00000398189.3
ENST00000541105.1 |
APOF
|
apolipoprotein F |
chr7_-_97619508 | 3.47 |
ENST00000257627.4
|
OCM2
|
oncomodulin 2 |
chrX_+_9431324 | 3.47 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr3_-_195938256 | 3.41 |
ENST00000296326.3
|
ZDHHC19
|
zinc finger, DHHC-type containing 19 |
chr19_-_2085323 | 3.38 |
ENST00000591638.1
|
MOB3A
|
MOB kinase activator 3A |
chr2_+_204571198 | 3.37 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
chr16_+_28943260 | 3.37 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr12_-_7899958 | 3.37 |
ENST00000360345.3
|
CLEC4C
|
C-type lectin domain family 4, member C |
chr12_-_7902069 | 3.33 |
ENST00000542353.1
ENST00000540085.1 |
CLEC4C
|
C-type lectin domain family 4, member C |
chr16_+_28874345 | 3.31 |
ENST00000566209.1
|
SH2B1
|
SH2B adaptor protein 1 |
chr1_+_158815588 | 3.26 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr1_-_36937075 | 3.26 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr12_-_57644952 | 3.26 |
ENST00000554578.1
ENST00000546246.2 ENST00000553489.1 ENST00000332782.2 |
STAC3
|
SH3 and cysteine rich domain 3 |
chr16_-_30393752 | 3.25 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
chr1_-_150693318 | 3.22 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
chr4_-_39033963 | 3.21 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
chr17_+_4835580 | 3.17 |
ENST00000329125.5
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide |
chr14_+_22591276 | 3.12 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr16_+_12058961 | 3.12 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr12_-_6756559 | 3.11 |
ENST00000536350.1
ENST00000414226.2 ENST00000546114.1 |
ACRBP
|
acrosin binding protein |
chr16_-_68034470 | 3.11 |
ENST00000412757.2
|
DPEP2
|
dipeptidase 2 |
chr19_+_17865011 | 3.10 |
ENST00000596462.1
ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1
|
FCH domain only 1 |
chr7_+_141695671 | 3.10 |
ENST00000497673.1
ENST00000475668.2 |
MGAM
|
maltase-glucoamylase (alpha-glucosidase) |
chr17_+_47448102 | 3.08 |
ENST00000576461.1
|
RP11-81K2.1
|
Uncharacterized protein |
chr11_+_65647280 | 3.02 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
chr22_+_18260077 | 3.01 |
ENST00000600723.1
|
LINC00528
|
long intergenic non-protein coding RNA 528 |
chr16_+_30194118 | 2.99 |
ENST00000563778.1
|
CORO1A
|
coronin, actin binding protein, 1A |
chr1_-_186365908 | 2.99 |
ENST00000598663.1
|
AL596220.1
|
Uncharacterized protein |
chr19_+_41092680 | 2.98 |
ENST00000594298.1
ENST00000597396.1 |
SHKBP1
|
SH3KBP1 binding protein 1 |
chr17_+_7338737 | 2.97 |
ENST00000323206.1
ENST00000396568.1 |
TMEM102
|
transmembrane protein 102 |
chr1_-_9714644 | 2.96 |
ENST00000377320.3
|
C1orf200
|
chromosome 1 open reading frame 200 |
chr19_+_42824511 | 2.94 |
ENST00000601644.1
|
TMEM145
|
transmembrane protein 145 |
chr14_+_76072096 | 2.91 |
ENST00000555058.1
|
FLVCR2
|
feline leukemia virus subgroup C cellular receptor family, member 2 |
chr2_-_198062758 | 2.91 |
ENST00000328737.2
|
ANKRD44
|
ankyrin repeat domain 44 |
chr19_+_999601 | 2.89 |
ENST00000594393.1
|
AC004528.1
|
Uncharacterized protein |
chr7_+_141695633 | 2.89 |
ENST00000549489.2
|
MGAM
|
maltase-glucoamylase (alpha-glucosidase) |
chr7_+_5920429 | 2.88 |
ENST00000242104.5
|
OCM
|
oncomodulin |
chr16_+_67678818 | 2.85 |
ENST00000334583.6
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
chr5_-_157161727 | 2.84 |
ENST00000599823.1
|
AC026407.1
|
Uncharacterized protein |
chr12_+_42624050 | 2.82 |
ENST00000601185.1
|
AC020629.1
|
Uncharacterized protein |
chr2_+_208527094 | 2.81 |
ENST00000429730.1
|
AC079767.4
|
AC079767.4 |
chr1_+_247582097 | 2.80 |
ENST00000391827.2
|
NLRP3
|
NLR family, pyrin domain containing 3 |
chr16_+_30387141 | 2.78 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr19_-_2096259 | 2.77 |
ENST00000588048.1
ENST00000357066.3 |
MOB3A
|
MOB kinase activator 3A |
chr9_+_131445703 | 2.76 |
ENST00000454747.1
|
SET
|
SET nuclear oncogene |
chr3_+_186739636 | 2.73 |
ENST00000440338.1
ENST00000448044.1 |
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr1_+_207070775 | 2.68 |
ENST00000391929.3
ENST00000294984.2 ENST00000367093.3 |
IL24
|
interleukin 24 |
chr5_+_54320078 | 2.67 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr1_-_153348067 | 2.64 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr16_+_68071816 | 2.64 |
ENST00000562246.1
|
DUS2
|
dihydrouridine synthase 2 |
chr6_+_35704855 | 2.63 |
ENST00000288065.2
ENST00000373866.3 |
ARMC12
|
armadillo repeat containing 12 |
chr19_+_1077393 | 2.61 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr17_+_7254184 | 2.61 |
ENST00000575415.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_+_160765919 | 2.61 |
ENST00000341032.4
ENST00000368041.2 ENST00000368040.1 |
LY9
|
lymphocyte antigen 9 |
chr14_+_22204418 | 2.58 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
chr20_+_361261 | 2.58 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
chr10_-_125853200 | 2.57 |
ENST00000421115.1
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr19_+_55014085 | 2.55 |
ENST00000351841.2
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2 |
chr19_-_48547294 | 2.54 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr7_+_73624276 | 2.52 |
ENST00000475494.1
ENST00000398475.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chr16_+_30087288 | 2.51 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
chr1_-_109203685 | 2.50 |
ENST00000402983.1
ENST00000420055.1 |
HENMT1
|
HEN1 methyltransferase homolog 1 (Arabidopsis) |
chr22_+_24819565 | 2.49 |
ENST00000424232.1
ENST00000486108.1 |
ADORA2A
|
adenosine A2a receptor |
chr14_-_65785502 | 2.48 |
ENST00000553754.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
chr19_+_47840346 | 2.47 |
ENST00000600626.1
|
C5AR2
|
complement component 5a receptor 2 |
chrX_-_70838306 | 2.45 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
chr1_+_160765884 | 2.44 |
ENST00000392203.4
|
LY9
|
lymphocyte antigen 9 |
chr16_-_69390209 | 2.42 |
ENST00000563634.1
|
RP11-343C2.9
|
Uncharacterized protein |
chr16_-_68033356 | 2.41 |
ENST00000393847.1
ENST00000573808.1 ENST00000572624.1 |
DPEP2
|
dipeptidase 2 |
chr12_+_123259063 | 2.39 |
ENST00000392441.4
ENST00000539171.1 |
CCDC62
|
coiled-coil domain containing 62 |
chr20_+_55099542 | 2.38 |
ENST00000371328.3
|
FAM209A
|
family with sequence similarity 209, member A |
chr12_-_53601055 | 2.38 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
chr1_-_160832642 | 2.37 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr9_-_72435576 | 2.36 |
ENST00000453410.1
ENST00000526458.1 ENST00000439418.1 |
C9orf135-AS1
|
C9orf135 antisense RNA 1 (head to head) |
chr3_+_39371255 | 2.34 |
ENST00000414803.1
ENST00000545843.1 |
CCR8
|
chemokine (C-C motif) receptor 8 |
chr12_+_54892550 | 2.34 |
ENST00000545638.2
|
NCKAP1L
|
NCK-associated protein 1-like |
chr17_-_3595181 | 2.34 |
ENST00000552050.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr12_-_7904201 | 2.34 |
ENST00000354629.5
|
CLEC4C
|
C-type lectin domain family 4, member C |
chr4_-_6692246 | 2.34 |
ENST00000499502.2
|
RP11-539L10.2
|
RP11-539L10.2 |
chr8_-_27941359 | 2.33 |
ENST00000418860.1
|
NUGGC
|
nuclear GTPase, germinal center associated |
chr14_+_22931924 | 2.33 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
chr10_+_96443204 | 2.32 |
ENST00000339022.5
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
chr5_+_54398463 | 2.32 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
chr16_+_12059050 | 2.31 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr12_+_2912363 | 2.29 |
ENST00000544366.1
|
FKBP4
|
FK506 binding protein 4, 59kDa |
chr7_-_99381798 | 2.29 |
ENST00000415003.1
ENST00000354593.2 |
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
chr19_-_14889349 | 2.28 |
ENST00000315576.3
ENST00000392967.2 ENST00000346057.1 ENST00000353876.1 ENST00000353005.1 |
EMR2
|
egf-like module containing, mucin-like, hormone receptor-like 2 |
chr6_-_128239685 | 2.28 |
ENST00000368250.1
|
THEMIS
|
thymocyte selection associated |
chr5_+_76145920 | 2.28 |
ENST00000317593.4
|
S100Z
|
S100 calcium binding protein Z |
chrX_-_70329118 | 2.27 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
chr1_+_160765860 | 2.27 |
ENST00000368037.5
|
LY9
|
lymphocyte antigen 9 |
chr16_+_72042487 | 2.25 |
ENST00000572887.1
ENST00000219240.4 ENST00000574309.1 ENST00000576145.1 |
DHODH
|
dihydroorotate dehydrogenase (quinone) |
chr17_-_3599327 | 2.25 |
ENST00000551178.1
ENST00000552276.1 ENST00000547178.1 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr12_+_53774423 | 2.24 |
ENST00000426431.2
|
SP1
|
Sp1 transcription factor |
chr19_+_14491948 | 2.23 |
ENST00000358600.3
|
CD97
|
CD97 molecule |
chr6_+_35704804 | 2.22 |
ENST00000373869.3
|
ARMC12
|
armadillo repeat containing 12 |
chr19_-_8642289 | 2.21 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr6_-_31763721 | 2.20 |
ENST00000375663.3
|
VARS
|
valyl-tRNA synthetase |
chr13_+_50202435 | 2.20 |
ENST00000282026.1
|
ARL11
|
ADP-ribosylation factor-like 11 |
chr7_+_76107444 | 2.20 |
ENST00000435861.1
|
DTX2
|
deltex homolog 2 (Drosophila) |
chr17_+_7982800 | 2.19 |
ENST00000399413.3
|
AC129492.6
|
AC129492.6 |
chr19_-_54850417 | 2.19 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
chr17_-_5321549 | 2.19 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
chr3_+_172034218 | 2.19 |
ENST00000366261.2
|
AC092964.1
|
Uncharacterized protein |
chr9_-_117160738 | 2.19 |
ENST00000448674.1
|
RP11-9M16.2
|
RP11-9M16.2 |
chr17_-_34524157 | 2.18 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
chr17_-_42994283 | 2.17 |
ENST00000593179.1
|
GFAP
|
glial fibrillary acidic protein |
chr9_-_139927462 | 2.17 |
ENST00000314412.6
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
chr12_+_56324756 | 2.17 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr8_-_126963387 | 2.17 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr19_+_16254488 | 2.17 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chr1_-_150738261 | 2.16 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr7_+_142423143 | 2.16 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
chr12_-_51718436 | 2.13 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
chr7_-_75005425 | 2.13 |
ENST00000594196.1
|
AC006014.1
|
Uncharacterized protein |
chr19_+_24009879 | 2.12 |
ENST00000354585.4
|
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chr15_-_90358564 | 2.12 |
ENST00000559874.1
|
ANPEP
|
alanyl (membrane) aminopeptidase |
chr9_-_71161505 | 2.09 |
ENST00000446290.1
|
RP11-274B18.2
|
RP11-274B18.2 |
chr22_-_37571089 | 2.08 |
ENST00000453962.1
ENST00000429622.1 ENST00000445595.1 |
IL2RB
|
interleukin 2 receptor, beta |
chr19_+_46003056 | 2.07 |
ENST00000401593.1
ENST00000396736.2 |
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
chr17_+_8869157 | 2.06 |
ENST00000585297.1
|
CTB-41I6.1
|
CTB-41I6.1 |
chr14_+_22964877 | 2.06 |
ENST00000390494.1
|
TRAJ43
|
T cell receptor alpha joining 43 |
chr17_-_3595042 | 2.05 |
ENST00000552723.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr12_+_32115400 | 2.04 |
ENST00000381054.3
|
KIAA1551
|
KIAA1551 |
chr4_-_38784572 | 2.03 |
ENST00000308973.4
ENST00000361424.2 |
TLR10
|
toll-like receptor 10 |
chr12_-_127256858 | 2.03 |
ENST00000542248.1
ENST00000540684.1 |
LINC00944
|
long intergenic non-protein coding RNA 944 |
chr12_-_6677422 | 2.02 |
ENST00000382421.3
ENST00000545200.1 ENST00000399466.2 ENST00000536124.1 ENST00000540228.1 ENST00000542867.1 ENST00000545492.1 ENST00000322166.5 ENST00000545915.1 |
NOP2
|
NOP2 nucleolar protein |
chr19_-_18197799 | 2.01 |
ENST00000430026.3
ENST00000593993.2 |
IL12RB1
|
interleukin 12 receptor, beta 1 |
chr1_-_100231349 | 2.01 |
ENST00000287474.5
ENST00000414213.1 |
FRRS1
|
ferric-chelate reductase 1 |
chr14_-_23292596 | 2.01 |
ENST00000554741.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr19_+_52264449 | 2.00 |
ENST00000599326.1
ENST00000598953.1 |
FPR2
|
formyl peptide receptor 2 |
chr12_-_7899935 | 1.99 |
ENST00000543765.1
|
CLEC4C
|
C-type lectin domain family 4, member C |
chr7_+_102196256 | 1.99 |
ENST00000341656.4
|
SPDYE2
|
speedy/RINGO cell cycle regulator family member E2 |
chr7_+_102292796 | 1.99 |
ENST00000436228.2
|
SPDYE2B
|
speedy/RINGO cell cycle regulator family member E2B |
chr7_+_98971863 | 1.98 |
ENST00000443222.1
ENST00000414376.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr17_+_7239821 | 1.98 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr12_+_147052 | 1.98 |
ENST00000594563.1
|
AC026369.1
|
Uncharacterized protein |
chr19_-_58204128 | 1.97 |
ENST00000597520.1
|
AC004017.1
|
Uncharacterized protein |
chr1_-_156269428 | 1.97 |
ENST00000339922.3
|
VHLL
|
von Hippel-Lindau tumor suppressor-like |
chr3_-_52029958 | 1.97 |
ENST00000294189.6
|
RPL29
|
ribosomal protein L29 |
chr15_-_38852251 | 1.96 |
ENST00000558432.1
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr1_-_160832670 | 1.96 |
ENST00000368032.2
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr22_-_37976082 | 1.96 |
ENST00000215886.4
|
LGALS2
|
lectin, galactoside-binding, soluble, 2 |
chr16_+_30484054 | 1.96 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr22_-_21984282 | 1.95 |
ENST00000398873.3
ENST00000292778.6 |
YDJC
|
YdjC homolog (bacterial) |
chr19_-_4302375 | 1.94 |
ENST00000600114.1
ENST00000600349.1 ENST00000595645.1 ENST00000301272.2 |
TMIGD2
|
transmembrane and immunoglobulin domain containing 2 |
chr1_-_109203648 | 1.94 |
ENST00000370031.1
|
HENMT1
|
HEN1 methyltransferase homolog 1 (Arabidopsis) |
chr1_-_739137 | 1.94 |
ENST00000599533.1
|
AL669831.1
|
Uncharacterized protein |
chr4_+_40201954 | 1.94 |
ENST00000511121.1
|
RHOH
|
ras homolog family member H |
chr3_+_48264816 | 1.94 |
ENST00000296435.2
ENST00000576243.1 |
CAMP
|
cathelicidin antimicrobial peptide |
chr14_-_23285069 | 1.93 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr8_-_102275131 | 1.93 |
ENST00000523121.1
|
KB-1410C5.2
|
KB-1410C5.2 |
chr17_-_34625719 | 1.92 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
chr5_-_140013275 | 1.92 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr1_-_224216371 | 1.91 |
ENST00000600307.1
|
AC138393.1
|
Uncharacterized protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.4 | 4.1 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
1.1 | 4.3 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.1 | 17.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.1 | 3.2 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
1.0 | 5.1 | GO:0032796 | uropod organization(GO:0032796) |
1.0 | 2.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
1.0 | 3.9 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
1.0 | 4.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.9 | 6.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.9 | 4.3 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.8 | 4.9 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.8 | 2.3 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.7 | 2.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.7 | 4.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 2.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.6 | 16.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.6 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 10.6 | GO:0043383 | negative T cell selection(GO:0043383) |
0.6 | 11.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 1.7 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.6 | 1.7 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.6 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.6 | 3.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.6 | 1.7 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 1.6 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) positive regulation of mast cell cytokine production(GO:0032765) mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.5 | 4.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.5 | 3.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 3.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.5 | 5.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 2.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.5 | 2.0 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.5 | 2.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.5 | 4.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.5 | 2.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 1.4 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.5 | 1.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.5 | 0.9 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.5 | 0.5 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.4 | 1.8 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.4 | 1.3 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.4 | 17.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 4.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 1.2 | GO:0070781 | response to biotin(GO:0070781) |
0.4 | 1.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 1.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 4.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 1.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.1 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 1.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.4 | 1.5 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.4 | 1.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 1.5 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 1.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 2.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.3 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 1.7 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.3 | 1.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.3 | 1.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.3 | 1.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 1.3 | GO:0060032 | notochord regression(GO:0060032) |
0.3 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 2.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.3 | 2.5 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.3 | 3.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 2.2 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 1.8 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 1.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 2.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.3 | 0.9 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.3 | 1.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 0.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 4.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.3 | GO:0039519 | modulation by virus of host autophagy(GO:0039519) |
0.3 | 3.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.3 | 2.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 1.1 | GO:0051413 | response to cortisone(GO:0051413) |
0.3 | 2.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 1.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 1.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.3 | 2.4 | GO:1901660 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.3 | 1.3 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.3 | 0.8 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.3 | 1.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.8 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.3 | 2.3 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.3 | 9.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 1.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 3.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 0.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.2 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.9 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.2 | 1.6 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.2 | 3.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 5.9 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.2 | 1.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 2.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 1.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 1.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 2.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 2.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 2.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 2.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.2 | 4.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.2 | 21.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.2 | 0.8 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 0.4 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
0.2 | 0.6 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
0.2 | 0.6 | GO:0035570 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.2 | 1.6 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 2.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 1.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.2 | 5.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 2.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.6 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.2 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.0 | GO:0010157 | response to chlorate(GO:0010157) |
0.2 | 1.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 0.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.2 | 0.6 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.2 | 2.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.7 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.2 | 0.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.2 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 1.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 1.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 3.0 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 4.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 1.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.2 | 1.9 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.2 | 1.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.2 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 1.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.6 | GO:0035803 | egg coat formation(GO:0035803) |
0.2 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 1.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 2.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 1.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.8 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 4.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.9 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 2.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 1.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 2.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.5 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.1 | 0.6 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.0 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 1.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.1 | 0.8 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.1 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.4 | GO:1902356 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.1 | 0.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 3.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 2.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 1.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 0.5 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
0.1 | 5.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 6.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 1.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 1.4 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 2.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.4 | GO:0046324 | regulation of glucose transport(GO:0010827) regulation of glucose import(GO:0046324) |
0.1 | 1.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 3.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 1.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.4 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 2.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.4 | GO:1900111 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.2 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 15.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.7 | GO:0060356 | leucine import(GO:0060356) |
0.1 | 1.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.8 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 1.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 3.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 17.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 2.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 3.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 5.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 3.1 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 2.2 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.5 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.1 | 0.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 2.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 3.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.7 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 3.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.6 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 1.7 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.1 | 4.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 2.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 3.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.2 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.1 | 1.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 2.7 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 1.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 1.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 2.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 5.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.9 | GO:0034349 | positive regulation of mitochondrial membrane potential(GO:0010918) glial cell apoptotic process(GO:0034349) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 1.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 5.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.5 | GO:1903772 | virus maturation(GO:0019075) regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 1.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.5 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 1.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 3.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.7 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 2.8 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 1.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 3.7 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 1.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 2.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 6.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.7 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.1 | 1.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 2.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 2.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.1 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 1.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.1 | 0.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 0.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 1.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.9 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 2.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.9 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 1.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.6 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
0.0 | 1.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.6 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.3 | GO:0044550 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.6 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 3.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.9 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 4.5 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.0 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.7 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.9 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
0.0 | 1.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.0 | 0.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 1.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 1.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 1.2 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.3 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.0 | 1.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 2.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.3 | GO:0043092 | L-amino acid import(GO:0043092) |
0.0 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 2.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.0 | 0.5 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 1.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 3.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 4.8 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.5 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 2.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.0 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 1.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 3.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 1.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.5 | GO:0009314 | response to radiation(GO:0009314) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.3 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 1.8 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 2.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 1.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.7 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 2.2 | GO:0045859 | regulation of protein kinase activity(GO:0045859) |
0.0 | 0.2 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.6 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.8 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.9 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.7 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 1.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 1.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 3.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.8 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.9 | GO:0042107 | cytokine biosynthetic process(GO:0042089) cytokine metabolic process(GO:0042107) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.7 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.0 | 3.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.3 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 4.9 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 1.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.2 | GO:0071174 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) |
0.0 | 0.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 1.0 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 18.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 12.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.7 | 2.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.6 | 5.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 1.6 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.5 | 15.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.5 | 2.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 2.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.5 | 2.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.4 | 4.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 2.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.4 | 16.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 2.7 | GO:0030891 | VCB c |